Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersTherapeutic Radiology Physician in Burlington, VT
NPI: 1053507434Primary Practice Location
University of Vermont Medical Center Inc
111 Colchester Ave, Burlington, VT
Primary Employer
Uvm Medical Center
uvmhealth.org
HQ Phone
Get M.D. Christopher's Phone Numberphone_androidMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardUT State Medical License
VT State Medical License
University of Utah Health
Residency • Radiation Oncology
2006 - 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77014Ct scan guidance for insertion of radiation therapy fields | 113 | 486 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 53 | 53 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 52 | 73 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 46 | 49 |
| 5 | 77263Complex radiation therapy planning | 45 | 46 |
Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.
Authors: Jason Hunt, Ying Hitchcock, Dennis Shrieve, Leechuan Andy Chen, Kenneth Grossmann
Publication Date: 2014-06-06
Authors: Karen Salzman, Howard Colman, Dennis Shrieve, Brett Johnson, Lindsay Burt
Journal: J Neurooncol
Publication Date: 2020-06-06
Authors: Garth Garrison, Farrah Khan
Journal: Ann Am Thorac Soc
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Paclitaxel, DRUG: Etoposide, BIOLOGICAL: Durvalumab, DRUG: Pemetrexed Disodium
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: RADIATION: Image Guided Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Etoposide, RADIATION: 3-Dimensional Conformal Radiation Therapy
